Legal Representation
Attorney
C. BRANDON BROWNING
USPTO Deadlines
Application History
37 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 30, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| May 2, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 2, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| May 2, 2025 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Nov 5, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Nov 5, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Nov 4, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 4, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 3, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 2, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| May 2, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| May 2, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 4, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 2, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Nov 2, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 2, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| May 2, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 7, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 7, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 15, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 30, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 30, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 30, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 30, 2023 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Nov 29, 2022 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Oct 27, 2022 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Oct 27, 2022 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Oct 27, 2022 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Oct 19, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 18, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 18, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 18, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 18, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 18, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 18, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 23, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 27, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Housemark for a full line of prescription pharmaceuticals for the treatment of cancer, anal fissures, cystic fibrosis; pharmaceuticals for treatment of cancer, and cystic fibrosis; pharmaceuticals exhibiting efficient drug release for the treatment of cancer, cystic fibrosis, and anal fissures
Class 042
Providing information about medical and scientific research; Providing information about medical and scientific research via a website
Classification
International Classes
005
042